Table 5 Cardiovascular measures in T2DM patients according to HbA1c levels
|  | HbA1c <6.5% | HbA1c ≥6.5% | P |
|---|---|---|---|
N | 40 | 85 | Â |
Age (years) | 58 ± 8 | 58 ± 10 | 0.74 |
Male:female | 25:15 | 60:25 | 0.37 |
T2DM duration (years) | 6.0 ± 5.2 | 7.6 ± 6.8 | 0.18 |
HbAc1 (%) | 6.1 ± 0.3 | 7.6 ± 0.9 | <0.0001 |
Carotid systolic BP (mmHg) | 119 ± 13 | 126 ± 14 | 0.01 |
cfPWV (m/s) | 8.0 ± 1.5 | 8.7 ± 1.9 | <0.05 |
Increased cfPWV (%) | 15.0 | 32.9 | <0.05 |
ccaPWV (m/s) | 8.3 ± 1.6 | 8.5 ± 1.8 | 0.31 |
LVMI (g/m2.7) | 46 ± 10 | 52 ± 10 | 0.005 |
LVH (%) | 35.0 | 58.8 | 0.01 |
e′ velocity (cm/s) | 10.1 ± 1.6 | 9.1 ± 1.7 | 0.001 |
Diastolic dysfunction (%) | 22.5 | 40.0 | <0.05 |
s′ velocity (cm/s) | 9.5 ± 1.5 | 8.9 ± 1.4 | <0.05 |
ess-MWS (%) | 105 ± 13 | 99 ± 16 | <0.05 |